Medicare Enrolled

Dr. Troy Sukkarieh, MD

Urology Physician · Freehold, NJ
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
501 IRON BRIDGE RD STE 5, Freehold, NJ 07728
7327807603
In practice since 2006 (19 years)
NPI: 1003913815 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Sukkarieh from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sukkarieh? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Sukkarieh

Dr. Troy Sukkarieh is an urology physician in Freehold, NJ, with 19 years of NPI registration. Based on federal Medicare data, Dr. Sukkarieh performed 10,841 Medicare services across 5,539 unique beneficiaries.

Between the years covered by Open Payments, Dr. Sukkarieh received a total of $812 from 15 pharmaceutical and/or device companies across 38 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Sukkarieh is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 9% volume in NJ $812 industry payments

Medicare Practice Summary

Medicare Utilization ↗
10,841
Medicare services
Top 9% in NJ for urology physician
5,539
Unique beneficiaries
$53
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~571 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
BCG treatment for bladder cancer 3,750 $2 $5
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
1,458 $68 $188
Limited ultrasound of pelvis
A focused ultrasound exam of the pelvic area to evaluate specific structures. This procedure provides images of the pelvis to assist in medical assessment.
1,016 $41 $168
Transrectal ultrasound of the pelvis
An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures.
714 $113 $340
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
425 $97 $274
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
395 $66 $179
Leuprolide acetate (for depot suspension), 7.5 mg 293 $133 $487
Complete ultrasound of retroperitoneum
An ultrasound examination of the structures located behind the abdominal cavity.
266 $91 $399
Limited retroperitoneal ultrasound
A focused ultrasound exam of the area behind the abdominal cavity to evaluate specific structures.
247 $49 $201
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
240 $83 $274
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
194 $109 $336
Cystourethroscopy
A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract.
186 $200 $890
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
164 $47 $116
Urine culture, bacterial colony count
A laboratory test that measures the number of bacteria growing in a urine sample to help identify infections.
157 $8 $33
Urine culture, bacterial identification
A laboratory test that grows and identifies bacteria from a urine sample to detect infections.
154 $8 $34
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
148 $130 $412
Additional urethral implant in prostate
Placement of an additional implant into the urethra within the prostate gland using an endoscope.
137 $42 $5,607
Electronic assessment of bladder emptying
A test that uses electronic monitoring to evaluate how well the bladder empties urine.
99 $11 $319
Subcutaneous or intramuscular chemotherapy injection
This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle.
85 $26 $121
Bladder instillation of anti-cancer drug
A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue.
75 $73 $1,459
Complicated insertion of bladder tube 71 $130 $400
Bacterial culture, aerobic
A laboratory test that grows and identifies bacteria capable of surviving in oxygen. The results help determine the presence of specific aerobic microorganisms.
65 $8 $33
Antibiotic sensitivity test
A laboratory test that determines which antibiotics, antifungals, or antivirals are effective against a specific microorganism using microdilution or agar dilution methods.
65 $8 $13
Bladder ultrasound after voiding
An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder.
52 $10 $115
Imaging of urinary tract with contrast
An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures.
42 $20 $59
Simple insertion of temporary bladder tube
A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder.
38 $52 $425
Endoscopic removal of foreign body, stone, or stent from urethra or bladder
A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item.
35 $271 $1,400
Prostate gland biopsy
A procedure to remove small samples of tissue from the prostate gland for laboratory examination.
32 $196 $1,443
Urethral implant insertion in prostate
A single implant is placed into the urethra within the prostate gland using an endoscope.
31 $168 $7,252
Urethral dilation using endoscope
A procedure to widen the urethra using a thin, lighted tube called an endoscope. This helps to open a narrowed urethral passage.
30 $284 $1,143
Ureteral stent insertion via endoscope
A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder.
30 $84 $2,500
Ultrasound of scrotum
An imaging test that uses sound waves to create pictures of the scrotum and its contents. It helps evaluate the testicles and surrounding structures.
28 $80 $236
Shock wave crushing of kidney stones
A procedure that uses shock waves to break kidney stones into smaller pieces so they can pass more easily from the body.
22 $482 $5,085
Bladder tumor removal via endoscope
This procedure involves using an endoscope to destroy or remove a large growth from the bladder.
18 $317 $4,444
Endoscopic removal of kidney or ureter stone
A procedure to remove or manipulate a stone in the kidney or ureter using an endoscope. The endoscope is a thin, lighted tube inserted into the body to visualize and treat the stone.
16 $303 $4,624
Insertion of temporary bladder tube 14 $39 $326
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
13 $101 $256
Ureteral stone crushing with stent insertion
An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open.
12 $359 $2,290
Transurethral prostate removal with electrocautery
This procedure involves removing the prostate gland through the urethra using an endoscope and an electrocautery knife to control bleeding.
12 $613 $4,090
Urinalysis with microscopic exam
A urine test performed manually that includes examining the sample under a microscope to check for abnormalities.
12 $3 $13
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.7% high complexity
22.9% medium
76.4% routine

Industry Payment Transparency

Open Payments through 2023 ↗
$812
Total received (2018-2023)
Avg $135/year across 6 years
Bottom 27% in NJ for urology physician
15
Companies
38
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$797 (98.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$15 (1.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2023
$128
2022
$41
2021
$70
2020
$18
2019
$115
2018
$440

Payments by company (2023)

Consulting
Speaking
Meals & Travel
Research
Teleflex LLC
$128
Top 3 companies account for 100.0% of 2023 payments
All-time payments by company (2018-2023) ›
Medtronic USA, Inc.
$280
Teleflex LLC
$174
BOSTON SCIENTIFIC CORPORATION
$101
NeoTract Inc.
$91
PROCEPT BioRobotics Corporation
$31
Rochester Medical Corporation
$16
PFIZER INC.
$15
GENZYME CORPORATION
$15
Myovant Sciences Inc.
$14
Ethicon US, LLC
$14
SANOFI-AVENTIS U.S. LLC
$14
Bayer HealthCare Pharmaceuticals Inc.
$13
Astellas Pharma US Inc
$13
TOLMAR Pharmaceuticals, Inc.
$11
Olympus America Inc.
$11
Top 3 companies account for 68.4% of all-time payments
Associated products mentioned in payments ›
AquaBeam Robotic System · ECHELON FLEX Stapler · ELIGARD · GENERAL BPH · INTERSTIM · JEVTANA · MYRBETRIQ · ORGOVYX · UROLIFT · UroLift · UroLift System · VISERA ELITE II VIDEO SYSTEM CENTER · XTANDI · Xofigo
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an urology physician in Freehold?
Compare urology physicians in the Freehold area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology physicians within 10 mi
105
Per 100K population
16.3
County median income
$122,727
Nearest hospital
CENTRASTATE MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2023
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Sukkarieh is a clinical cardiology specialist, with above-average Medicare volume (top 9% in NJ), with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Sukkarieh experienced with bcg treatment for bladder cancer?
Based on Medicare claims data, Dr. Sukkarieh performed 3,750 bcg treatment for bladder cancer services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sukkarieh receive payments from pharmaceutical companies?
Yes. Dr. Sukkarieh received a total of $812 from 15 companies across 38 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sukkarieh's costs compare to other urology physicians in Freehold?
Dr. Sukkarieh's average Medicare payment per service is $53. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sukkarieh) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →